Matching slides 5,849
Current window 4,561-4,590
Pages 195
Rows per page 30
Slide function: Frame Problemclear collectionreset all

Slide function

4,561-4,590 of 5,849

filter-aware
04
Uses a visual metaphor of a fax machine to emphasize outdated technology.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations Beat · ProblemLoop · Voice Of Customer1 hit
10
Uses a visual comparison framework to illustrate the 'Goldilocks' problem in drug development.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Problem1 hit
25
Includes a specific callout for a Blackbox warning on existing competitors.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
29
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
30
Includes a biological process diagram and a gene expression heatmap.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
15
The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needsLoop · Cost Of Inaction1 hit
37
The slide uses a stacked bar chart to show mutation incidence and a comparison table to contrast clinical outcomes across different indications.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
07
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
22
The slide uses a hierarchical clustering heatmap (dendrograms on top and left) to visualize drug sensitivity across 80 small molecules.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
60
The heatmap displays AUC (Response) values across 16 patient samples for three different treatments.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
06
Uses a value-chain style diagram to show the complexity and manual communication flow.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a hub-and-spoke style diagram overlaid on a world map to connect specific industry pain points to the global supply chain.Freightos | Investor Presentation Deck | 34 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses visual evidence (screenshots) to expose a gap in the current market offerings.HeartBeam | Results Presentation Deck | 19 slides · HeartBeam
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
20
The slide uses a visual list of four vertical cards to present the challenges.Hugo Boss | Investor Presentation Deck | 24 slides · Hugo Boss
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
03
This is a classic 'problem-solution' framing slide.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Uses a hub-and-spoke diagram to illustrate the central problem of neurotoxicity and its four primary negative consequences.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
19
The slide uses a causal chain framework to link cellular pathology to systemic organ damage.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Beat · Competitive AnalysisLoop · Golden Circle1 hit
06
Uses a hub-and-spoke diagram to illustrate the negative impacts of a central problem.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
18
The slide uses a causal chain to link cellular pathology to systemic organ damage.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
07
Includes a cartoon illustration of a cell/virus character.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
19
The slide uses a causal chain framework to link cellular pathology to systemic organ damage.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Traction1 hit
46
The bubble chart maps mPFS against patient treatment history; the table highlights poor outcomes and high toxicity across lines of therapy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
06
The slide uses a medical context to establish the severity of the condition and the unmet medical need.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
Uses a visual timeline/process flow to explain the disease progression.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
16
The slide highlights both the clinical urgency and the commercial orphan disease opportunity.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
03
Nemaura Medical | Investor Presentation Deck | 29 slidesNemaura Medical | Investor Presentation Deck | 29 slides · Nemaura Medical
Conference presentation Investor relations Beat · Problem1 hit
04
Nemaura Medical | Investor Presentation Deck | 29 slidesNemaura Medical | Investor Presentation Deck | 29 slides · Nemaura Medical
Conference presentation Investor relations Beat · Problem1 hit
07
Uses a visual process flow to contrast standard therapy failure with Nuvalent's mechanism.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a medical illustration to map specific TRK receptor inhibition side effects to anatomical locations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
Uses a contrast-pairs framework to define the problem space.Sonder | Investor Presentation Deck | 27 slides · Sonder
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit